Dustin Sjuts
2019
In 2019, Dustin Sjuts earned a total compensation of $801K as Chief Commercial Officer at Revance Therapeutics.
Compensation breakdown
| Bonus | $50,000 |
|---|---|
| Non-Equity Incentive Plan | $183,902 |
| Option Awards | $99,927 |
| Salary | $378,333 |
| Stock Awards | $43,075 |
| Other | $45,786 |
| Total | $801,023 |
Sjuts received $378.3K in salary, accounting for 47% of the total pay in 2019.
Sjuts also received $50K in bonus, $183.9K in non-equity incentive plan, $99.9K in option awards, $43.1K in stock awards and $45.8K in other compensation.
Rankings
In 2019, Dustin Sjuts' compensation ranked 10,211th out of 13,971 executives tracked by ExecPay. In other words, Sjuts earned more than 26.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,211 out of 13,971 | 27th |
Division Manufacturing | 4,131 out of 5,701 | 28th |
Major group Chemicals And Allied Products | 1,575 out of 2,200 | 28th |
Industry group Drugs | 1,349 out of 1,886 | 29th |
Industry Pharmaceutical Preparations | 1,005 out of 1,398 | 28th |
Source: SEC filing on March 26, 2020.
Sjuts' colleagues
We found five more compensation records of executives who worked with Dustin Sjuts at Revance Therapeutics in 2019.
2019
Mark Foley
Revance Therapeutics
Chief Executive Officer
2019
L Browne
Revance Therapeutics
Chief Executive Officer
2019
Abhay Joshi
Revance Therapeutics
Chief Operating Officer
2019
Caryn McDowell
Revance Therapeutics
General Counsel
2019
Tobin Schilke
Revance Therapeutics